Published in BMJ on June 12, 1999
Involvement of hypoxia-inducible factors in the dysregulation of oxygen homeostasis in sepsis. Cardiovasc Hematol Disord Drug Targets (2015) 0.78
Echocardiography in the critically ill: current and potential roles. Intensive Care Med (2005) 3.28
Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA (1993) 2.82
Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine. Intensive Care Med (1997) 2.65
Reactive oxygen species in acute lung injury. Eur Respir J (1998) 2.50
Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med (1999) 2.07
Lung volume reduction surgery: a quality operation? Lancet (2001) 2.01
Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med (1999) 1.93
Clinical experience with the oxygen concentrator. Br Med J (Clin Res Ed) (1983) 1.80
Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med (1995) 1.75
Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med (2001) 1.74
The pathogenesis of lung injury following pulmonary resection. Eur Respir J (2000) 1.69
Adenosine as a vasodilator in primary pulmonary hypertension. Circulation (1991) 1.63
Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther (1986) 1.62
Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol (1993) 1.56
G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J (2000) 1.53
Splenic rupture following cardiopulmonary resuscitation. Resuscitation (1997) 1.50
Continuous veno-venous haemofiltration following cardio-pulmonary bypass. Indications and outcome in 35 patients. Intensive Care Med (1993) 1.46
Reduced mortality in association with the acute respiratory distress syndrome (ARDS). Thorax (1998) 1.45
Acute respiratory distress syndrome ("ARDS"): no more than a severe acute lung injury? BMJ (1993) 1.43
The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest (1995) 1.43
ECMO in adults for severe respiratory failure finally comes of age: just in time? Thorax (2010) 1.42
Activated protein C: the cure for sepsis - again? Anaesthesia (2001) 1.41
Blood lactate and mixed venous-arterial PCO2 gradient as indices of poor peripheral perfusion following cardiopulmonary bypass surgery. Intensive Care Med (1991) 1.41
Delivery dependent oxygen consumption: asking the wrong questions and not getting any answers. Crit Care Med (1993) 1.40
Production of nitric oxide during surgery involving cardiopulmonary bypass. Crit Care Med (1998) 1.39
Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med (2000) 1.30
Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br J Pharmacol (1988) 1.27
The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J (1990) 1.24
Hemodynamic and metabolic therapy in critically ill patients. N Engl J Med (2001) 1.22
KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J (2004) 1.22
Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun (1993) 1.21
The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med (1987) 1.18
Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol (2001) 1.15
Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg (2000) 1.15
Influence of antigen dosage on kinetics of hemagglutinating antibody production. J Immunol (1965) 1.14
Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis (1991) 1.13
Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels. Intensive Care Med (2002) 1.10
The management of adult respiratory distress syndrome: 1. Br J Hosp Med (1989) 1.09
Pulmonary perfusion in supine and prone positions: an electron-beam computed tomography study. J Appl Physiol (1985) (2001) 1.09
Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med (1996) 1.07
Is bleomycin-detectable iron present in the plasma of patients with septic shock? Intensive Care Med (1997) 1.07
Legal safeguards for the audit process. Are essential for effective clinical governance. BMJ (1999) 1.07
The management of adult respiratory distress syndrome: 2. Br J Hosp Med (1990) 1.07
Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med (1997) 1.06
Value of cytology for detecting endometrial abnormalities in climacteric women receiving hormone replacement therapy. Br Med J (1979) 1.06
Identification of futility in intensive care. Lancet (1994) 1.05
Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax (2006) 1.05
Acute respiratory distress syndrome. Lancet (1999) 1.04
Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J (2003) 1.03
Short burst oxygen treatment for breathlessness in chronic obstructive airways disease. Thorax (1986) 1.02
Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol (1992) 1.02
Iron and the redox status of the lungs. Free Radic Biol Med (2002) 1.02
Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) (1998) 1.01
Evidence for two P2-purinoceptor subtypes in human small pulmonary arteries. Br J Pharmacol (1989) 1.00
Recurrent and fatal haemoptysis caused by an atheromatous abdominal aortic aneurysm. Thorax (1990) 1.00
Characterization and distribution of P2-purinoceptor subtypes in rat pulmonary vessels. J Pharmacol Exp Ther (1989) 1.00
Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br J Pharmacol (1990) 0.99
Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia (1992) 0.99
Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea-pig pulmonary artery. Br J Pharmacol (1991) 0.97
Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet (1999) 0.96
Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit Care Med (1997) 0.96
Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway. Biochem Biophys Res Commun (1997) 0.96
Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med (1996) 0.95
Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U46619. Eur J Pharmacol (1985) 0.95
The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull (1999) 0.94
Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide. Am J Respir Crit Care Med (1999) 0.94
L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. Br J Clin Pharmacol (1993) 0.94
Haem oxygenase shows pro-oxidant activity in microsomal and cellular systems: implications for the release of low-molecular-mass iron. Biochem J (1999) 0.94
Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun (1996) 0.93
Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci (Lond) (1996) 0.93
The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS. Thorax (2002) 0.93
Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J (1999) 0.93
Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery. J Pharmacol Exp Ther (1992) 0.92
Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J (1997) 0.92
Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology (1999) 0.91
Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. Chest (1994) 0.91
Recurrent bleeding from the lower segment scar--a late complication of Caesarean section. Br J Obstet Gynaecol (1975) 0.89
Acute respiratory distress syndrome caused by pulmonary and extrapulmonary injury: a comparative CT study. Radiology (2001) 0.89
Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg (1993) 0.89
In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am J Physiol (1995) 0.89
Extracorporeal membrane oxygenation: a breath of fresh air or yesterday's treatment? Thorax (1991) 0.88
Abnormal tissue oxygenation and cardiovascular changes in endotoxemia. Am J Respir Crit Care Med (1999) 0.88
PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-kappaB-dependent proinflammatory activation of alveolar epithelial cells. Br J Pharmacol (2008) 0.87
Tissue oxygenation and perfusion in endotoxemia. Am J Physiol (1996) 0.87
The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Med (2000) 0.87
Ligustrazine is a vasodilator of human pulmonary and bronchial arteries. Eur J Pharmacol (1990) 0.87
Allocation of resources in intensive care: a transatlantic perspective. Lancet (1994) 0.87
Lung injury following pulmonary resection in the isolated, blood-perfused rat lung. Eur Respir J (1999) 0.86
Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med (1998) 0.86
Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol (1992) 0.86
Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery. Br J Pharmacol (1997) 0.86
Plasma exudation and oedema in asthma. Br Med Bull (1992) 0.86
Vagal stimulation induces increased pulmonary vascular permeability in guinea pig. Am J Respir Crit Care Med (1994) 0.86
Cyclooxygenase-2 as a therapeutic target. Inflamm Res (1998) 0.86
Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic Res (1994) 0.86
Lung injury in patients following thoracotomy. Thorax (1995) 0.85
Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release. FASEB J (1999) 0.84
The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol (2000) 0.84
Management of adult respiratory distress syndrome. Lancet (1992) 0.84
Postoperative lung injury and oxidative damage in patients undergoing pulmonary resection. Eur Respir J (1998) 0.84